Multidisciplinary Management of Severe COPD
Copd, COPD Exacerbation
About this trial
This is an interventional prevention trial for Copd focused on measuring COPD, Multidisciplinary management, COPD exacerbation
Eligibility Criteria
Inclusion Criteria:
- Male or female patients, aged ≥40 years.
- Smokers or ex-smokers (≥10 pack-year).
- Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a clinically suspected diagnosis of exacerbations of COPD that prompt the discharging physician to refer the patient to the COPD Center.
- Signed informed concent form.
Exclusion Criteria:
- Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative diagnoses not related to patients with COPD (e.g., chest wall trauma, neurological disorders, sepsis, cancer and anemia).
- Already enrolled in other studies perceived to interfere with this protocol.
- In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis).
- Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or who make it impossible for the patients to participate into the study, evidence of alcohol or drug abuse, dementia, severe psychiatric disorder).
- Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU.
- Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care.
- At the discretion of the recruiting clinician would not be able to be considered for the study.
Sites / Locations
- COPD-CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Multidisciplinary, holistic and patient-centered care
Standard care
Based on the outcome from the assessment and disease phenotype, personalized care plans will be prepared and given to the patients, including dietary program, adjusted exercise program, psychological counselling, treatment of comorbidities etc. Patients will come for planned follow-up visits, according to the protocol (total 5 visits).
The control group will be recruited from the Swedish Airway Register at the end of the study. Selection will be based on propensity score matching to the intervention group.